255 results match your criteria: "From Harvard Medical School[Affiliation]"
N Engl J Med
December 2019
From Harvard Medical School, Boston (P.A.C.); and Global Life Sciences, Sidley Austin, New York (S.B.).
Cancer J
August 2020
From Harvard Medical School and CLL Center, Dana-Farber Cancer Institute, Boston, MA.
Inhibitors of PI3Kδ hold great potential for the therapy of chronic lymphocytic leukemia and B-cell malignancies. After initially exciting efficacy results with idelalisib, the first-in-class inhibitor, the emergence of unexpected and unpredictable autoimmune toxicities, worse in less heavily treated and younger patients, has decreased the use of the currently available inhibitors. Newer drugs in development are attempting to reduce toxicity with novel schedules and/or combinations.
View Article and Find Full Text PDFHarv Rev Psychiatry
May 2020
From Harvard Medical School; McLean Hospital, Belmont, MA; Massachusetts General Hospital, Boston, MA (Dr. Benson).
Electroconvulsive therapy (ECT) is a well-tolerated, well-established, and efficacious treatment in adults, particularly in the setting of severe mood and psychotic disorders. In children and adolescents, however, ECT is infrequently administered and likely underutilized. Results from older studies evaluating the utility of ECT in children and adolescents were mixed, but recent studies have supported ECT treatment success in these patients, with particularly high response rates for treating depression.
View Article and Find Full Text PDFHarv Rev Psychiatry
May 2020
From Harvard Medical School and Psychotic Disorders Division, McLean Hospital, Belmont, MA.
Learning Objectives: After participating in this activity, learners should be better able to:• Evaluate the double-dissociation approach to research in neuropsychology• Assess research aiming to provide evidence of double dissociation between neurobiological abnormalities and clinical presentations in psychiatry BACKGROUND: Psychiatric neuroscience research has grown exponentially, but it has not generated the desired breakthroughs in diagnosis, treatment development, or treatment selection. In many instances a given neurobiological abnormality is found in multiple clinical syndromes, and conversely, a clinical syndrome is associated with multiple neurobiological abnormalities. To the extent that neurobiology research is conducted to explain psychiatric manifestations, however, it should also provide insight into how certain brain abnormalities lead to one and not another specific clinical presentation-that is, "double-dissociation.
View Article and Find Full Text PDFHarv Rev Psychiatry
May 2020
From Harvard Medical School and Department of Psychiatry, Massachusetts General Hospital, Boston, MA.
Neurology
August 2019
From Harvard Medical School (J.H., J.D.S.); Harvard T.H. Chan School of Public Health (J.H.), Boston, MA; Department of Neurology (A.M.B.), Columbia University Medical Center, New York, NY; Laboratory for Cognitive Neurobiology, Department of Anatomy and Neurobiology (F.M.), Boston University School of Medicine, MA; and Departments of Pathology (D.H.O., M.P.F.) and Ataxia Unit, Cognitive Behavioral Neurology Unit, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Department of Neurology (J.D.H.), Massachusetts General Hospital, Boston.
N Engl J Med
August 2019
From Harvard Medical School, Boston (R.H.G., L.W.), and the Department of Medicine, Cambridge Hospital, Cambridge Health Alliance (R.H.G.), and Mount Auburn Hospital (L.W.), Cambridge - all in Massachusetts.
J Law Med Ethics
December 2018
Jessica N. Holtzman, B.A., holds a B.A. in Human Biology from Stanford University (Palo Alto, CA), is a medical student at Harvard Medical School (Boston, MA), and a research student at the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology at BIDMC. Daniel B. Kramer, M.D., M.P.H., earned his A. B. in Philosophy from Brown University (Providence, RI), M.D. from Harvard Medical School, and M.P.H. from the Harvard TH Chan School of Public Health (both in Boston, MA). He is a cardiac electrophysiologist at BIDMC, where he is also core faculty at the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology.
Harv Rev Psychiatry
May 2020
From Harvard Medical School; Beth Israel Deaconess Medical Center, Boston, MA (Dr. Steele); Brigham and Women's Hospital, Boston, MA (Dr. Steele); Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA (Drs. Pope and Kanayama).
The sport of competitive bodybuilding requires an intense regimen of weightlifting and dieting, often aided with muscle-building or fat-burning drugs, and culminating in an on-stage posing competition. Despite these rigorous demands, competitive bodybuilding is popular, with thousands of competitions performed annually around the world. Although many studies have addressed the psychological features of various sports and the athletes who compete in them, few have examined the psychological aspects of bodybuilding.
View Article and Find Full Text PDFN Engl J Med
July 2019
From Harvard Medical School, Boston (P.A.C.); and the Johns Hopkins Bloomberg School of Public Health, Baltimore (J.S.).
Harv Rev Psychiatry
May 2020
From Harvard Medical School (Dr. Tuttle); Massachusetts General Hospital, Boston, MA (Dr. Tuttle); University of Massachusetts Medical School (Dr. Niu); University of Massachusetts Memorial Medical Center (Dr. Niu); Shanghai Jiaotong University School of Medicine (Dr. Yang); Shanghai Mental Health Center, China (Dr. Yang); University of California-Davis (Dr. Xia); Brainefit LLC, Davis, CA (Dr. Xia).
N Engl J Med
May 2019
From Harvard Medical School, Boston (S.K., M.H.); and Brown University and the Center for Prisoner Health and Human Rights at the Miriam Hospital - both in Providence, RI (J.R.).
Anesthesiology
June 2019
From Harvard Medical School and the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Harv Rev Psychiatry
May 2020
From Harvard Medical School; Departments of Psychiatry (Mr. Henson; Drs. Peck and Torous) and Clinical Informatics (Dr. Torous), Beth Israel Deaconess Medical Center, Boston, MA.
J Biol Chem
February 2019
From Harvard Medical School, Boston, Massachusetts 02115 and Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114
N Engl J Med
January 2019
From Harvard Medical School, Boston, and the Department of Anthropology, Harvard University, Cambridge - both in Massachusetts (G.K.); and the Department of Anthropology, the Center for Social Medicine, and the Semel Institute of Neuroscience, University of California, Los Angeles, Los Angeles (P.B.).
Mr. M., an uninsured, 44-year-old Puerto Rican man with chronic back pain, diabetes, hypertension, asthma, and a history of incarceration presented to a free clinic with acute exacerbation of back pain triggered by carrying heavy loads of trash at work.
View Article and Find Full Text PDFN Engl J Med
March 2019
From Harvard Medical School, Boston (G.Q.D.); the Francis Crick Institute, London (R.L.-B.); and Université Paris Descartes, Imagine Inserm UMR1163, Service de Génétique Moléculaire, Hôpital Necker-Enfants Malades, Paris (J.S.).
Harv Rev Psychiatry
May 2020
From Harvard Medical School and VA Boston Healthcare System, Brockton Division, Brockton, MA.
Background: The Psychopharmacology Algorithm Project at the Harvard South Shore Program presents evidence-based recommendations considering efficacy, tolerability, safety, and cost. Two previous algorithms for unipolar nonpsychotic depression were published in 1993 and 1998. New studies over the last 20 years suggest that another update is needed.
View Article and Find Full Text PDFPlast Reconstr Surg
November 2018
From Harvard Medical School; the Center for Regenerative Medicine; the Harvard Stem Cell Institute; and the Division of Plastic and Reconstructive Surgery, Massachusetts General Hospital.
The clustered regularly interspaced short palindromic repeats (CRISPR) system of genome editing represents a major technological advance spanning all areas of genetics and downstream applications. CRISPR's potential impact on treating human disease encompasses all clinical specialties, including areas important to the plastic surgeon such as oncology, wound healing, immunology, and craniofacial malformations. Plastic surgeons should gain familiarity with this gene editing technology, and become active contributors and leaders in applying CRISPR to their respective areas of expertise.
View Article and Find Full Text PDFHarv Rev Psychiatry
June 2019
From Harvard Medical School; Brigham and Women's Hospital, Boston, MA (Drs. Hauptman and Acar); Boston Children's Hospital (Drs. Hauptman, Hammerness, Fogler, and Stafford).
Harv Rev Psychiatry
June 2019
From Harvard Medical School and Division of Depression and Anxiety, McLean Hospital, Belmont, MA.
Understanding the complexity and regular function of the human brain is an unresolved challenge that hampers the identification of disease-contributing components and mechanisms of psychiatric disorders. It is accepted that the majority of psychiatric disorders result from a complex interaction of environmental and heritable factors, and efforts to determine, for example, genetic variants contributing to the pathophysiology of these diseases are becoming increasingly successful. We also continue to discover new molecules with unknown functions that might play a role in brain physiology.
View Article and Find Full Text PDFNeurology
November 2018
From Harvard Medical School (K.-H.Y., O.M., N.P., I.S.K.), Boston; Harvard University (K.-H.Y., S.C.K.), Cambridge; Brigham and Women's Hospital (D.R.L.), Boston, MA; Aetna Inc. (K.F.), Hartford, CT; and Boston Children's Hospital (M.S., I.S.K.), MA.
N Engl J Med
November 2018
From Harvard Medical School (K.S., C.E., I.S.K., J.L., A.T.M., D.A.S.), Brigham and Women's Hospital (J.L.), and Massachusetts General Hospital (D.A.S.) - all in Boston; the National Institutes of Health Clinical Center (D.R.A., W.A.G., J.J.M., C.J.T.) and the National Human Genome Research Institute (A.L.W.), Bethesda, and the University of Maryland, College Park (A.M.C.-J., B.K., L.P.) - all in Maryland; Baylor College of Medicine, Houston (C.A.B., H.J.B., C.M.E., B.H.L., X.L., M.F.W., S.Y.); Stanford University, Stanford (J.A.B., C.R., M.T.W., E.A.A.), and the University of California, Los Angeles, Los Angeles (S.F.N., C.G.S.P.) - both in California; Vanderbilt University, Nashville (R.H., J.A.P.); HudsonAlpha Institute for Biotechnology, Huntsville, AL (H.J.J., E.A.W.); Oregon Health and Science University, Portland (D.M.K.); the Pacific Northwest National Laboratory, Richland, WA (T.O.M.); the University of Oregon, Eugene (J.H.P., M.W.); and Duke University, Durham, NC (V.S., N.M.W.).
Background: Many patients remain without a diagnosis despite extensive medical evaluation. The Undiagnosed Diseases Network (UDN) was established to apply a multidisciplinary model in the evaluation of the most challenging cases and to identify the biologic characteristics of newly discovered diseases. The UDN, which is funded by the National Institutes of Health, was formed in 2014 as a network of seven clinical sites, two sequencing cores, and a coordinating center.
View Article and Find Full Text PDFAnesthesiology
December 2018
From Harvard Medical School, Boston, Massachusetts (R.M.K.) Massachusetts General Hospital, Boston, Massachusetts (R.M.K.) CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain (J.V.) Research Unit, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain (J.V.).